Quick answer: Neurolens is Gabify's clinical-grade AI screening engine. From a short session video, it analyses up to 189 behavioural markers across nine developmental domains, maps them to clinical frameworks (DSM-5, CARS, ISAA), and — with expert review — produces a detailed clinical report in minutes, in 22+ Indian languages, from ₹799. It's validated by AIIMS Jodhpur and ICMR.
At the heart of the Gabify platform is Neurolens — the technology that makes fast, affordable, accessible developmental screening possible. This article explains exactly what Neurolens is, how it works, what it detects, and why its combination of AI and clinical rigour matters.
What is Neurolens?
Neurolens is an AI-powered developmental screening engine built to identify early signs of neurodevelopmental conditions — including autism, ADHD, and speech and language disorders — in children. It's designed to do in minutes what traditionally took weeks: produce a structured, clinically grounded picture of a child's development.
Crucially, Neurolens is not a replacement for clinicians. It's a clinical-grade screening tool that combines the speed and consistency of AI with the judgment of human experts — a "human-in-the-loop" model where the AI does the heavy lifting of detection and a qualified clinician reviews and validates the results.
How Neurolens works, step by step
Step 1: Input — upload a video or live screen
The process begins simply. A parent or clinician uploads a session video of the child — typically 10 to 15 minutes — or runs a live screen. The child just plays and interacts naturally; no clinical setting is required, which is what makes screening accessible from home.
Step 2: AI analysis across nine domains
Neurolens analyses the footage across nine developmental domains, examining behaviours such as speech, facial emotion, gaze, and motor patterns. The nine domains include:
- Social communication and autism markers
- Speech production and articulation
- Language comprehension
- Expressive language
- Attention and ADHD indicators
- Executive function and self-regulation
- Cognitive and intellectual functioning
- Pragmatics and social language
- Motor, sensory, and behavioural red flags
Step 3: 189-marker detection
Within the session, Neurolens detects up to 189 fine-grained behavioural markers — analysing things like gaze patterns, speech prosody, facial emotion, motor patterns, and social reciprocity. This is the kind of detailed, consistent measurement that's difficult for a human observer to achieve across a single session.
Step 4: Clinical-grade framework mapping
The detected markers are mapped to established clinical frameworks — DSM-5, CARS (Childhood Autism Rating Scale), and ISAA (Indian Scale for Assessment of Autism). This ensures the output speaks the language clinicians use and carries genuine clinical weight.
Step 5: Expert human-in-the-loop review
A qualified clinician reviews and validates the AI-generated analysis. This step is essential: it combines machine consistency with human judgment, ensuring the screening is responsible and trustworthy.
Step 6: A detailed clinical report
The family receives a 10–11 page digital clinical report — clear, structured, and available in 22+ Indian languages — with the findings and recommended next steps.
What makes Neurolens different
Clinical validation
Neurolens is validated by AIIMS Jodhpur and ICMR — two of India's most respected medical institutions. This institutional backing distinguishes it sharply from generic questionnaire apps with no clinical grounding.
Speed and accessibility
What once took weeks takes minutes. And because it works from a home video, it reaches families anywhere — vital in a country where specialists are scarce and most people live far from major clinics.
Affordability
At ₹799 — versus ₹5,000+ for traditional screening, an ~84% saving — Neurolens makes structured screening genuinely accessible, so families can screen early rather than as a last resort.
Multilingual by design
With reports in 22+ Indian languages, Neurolens reaches the many families that English-only tools leave behind in a country of 1,600+ languages.
Whole-child, multi-domain view
By assessing nine domains at once, Neurolens gives a comprehensive picture — especially valuable because neurodevelopmental conditions so often overlap. A single-condition checklist can't offer this.
Security and compliance
Neurolens operates within Gabify's compliance framework — ISO 13485, IEC 62304, HIPAA, and CDSCO alignment — protecting sensitive child data.
Screening, not diagnosis: an important distinction
It's essential to be clear about what Neurolens is for. It's a screening tool: it identifies whether a child shows signs that warrant further evaluation, and it guides families toward formal diagnosis and therapy. A formal diagnosis is a clinical determination made by qualified professionals. Neurolens is the powerful, accessible first step that makes that pathway faster and clearer — not a substitute for the clinician's final judgment.
How Neurolens connects to the rest of Gabify
Neurolens is the front door to the Gabify platform, and its real value emerges from what it connects to. A Neurolens screening establishes a clinical baseline that flows directly into Care (which connects the family to verified therapists) and Connect (which keeps everyone coordinated and tracks progress against that baseline over time). The screening isn't an endpoint — it's the start of a continuous, measurable journey. Within Connect, therapists can even draw on Neurolens-powered AI assessments directly inside their clinical workflow.
The bottom line
Neurolens is the engine that makes Gabify's mission possible: clinical-grade AI screening that analyses 189 markers across nine domains in minutes, grounded in DSM-5, CARS, and ISAA, validated by AIIMS Jodhpur and ICMR, delivered in 22+ Indian languages, from ₹799 — with a human expert always in the loop. It turns developmental screening from a slow, expensive, big-city privilege into something fast, affordable, and available to families across India.
To experience it, try Neurolens or book a screening from ₹799.